Title : Head-activator and the neuroectodermal differentiation of P19 mouse embryonal carcinoma cells.

Pub. Date : 1996 Mar 22

PMID : 8710207






3 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 P19 embryonal carcinoma cells differentiate into neuroectodermal derivates upon aggregation and treatment with retinoic acid (RA). Tretinoin interleukin 23, alpha subunit p19 Mus musculus
2 P19 embryonal carcinoma cells differentiate into neuroectodermal derivates upon aggregation and treatment with retinoic acid (RA). Tretinoin interleukin 23, alpha subunit p19 Mus musculus
3 Such RA-induced P19 cells, concomitant with neuronal differentiation, produce the neuropeptide head activator (HA) and release HA into the culture medium. Tretinoin interleukin 23, alpha subunit p19 Mus musculus